Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Hot Hemp Synthetic Cannabinoids: A Threat To Utah's Medical Cannabis Industry?

The medical cannabis industry in Utah is confusing since synthetic cannabinoid-laden products appeared in naturally abundant amounts on dispensary shelves. According to the FDA, CBD is synthesized from delta-8, THC and a variety of other cannabinoids that could pose "serious health risks."

Benzinga

FDA delays advisory committee meeting on over-the-counter birth control pill

WASHINGTON — The Food and Drug Administration on Wednesday postponed a critical advisory meeting on an application for the nation’s first over-the-counter birth control pill, citing the need “to review new information.”

Tribune News Service

Danica Patrick urges women to trust their ‘intuition’ after breast implant illness: ‘Get them removed’

The former Nascar driver says she began experiencing health issues three years after getting breast implants

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Is America about to enter a new era of psychedelics?

President Biden’s cannabis pardons have opened the doors to a reassessment of psychedelic drugs - with plenty of companies waiting eagerly in the wings

Evening Standard

FDA delays key advisory committee meeting on OTC birth control - Roll Call

The delay comes as Democrats agitate for increased access to birth control in the wake of the Supreme Court decision overturning Roe v. Wade.

Roll Call

High levels of cancer-causing chemical detected in dry shampoo, study finds

Benzene is a chemical which can raise the risk of some cancers after long-term exposure

The Independent UK

Mental Health Poll Finds Nearly 50% Of Americans Support Legalization Of Medicinal Psychedelics

The Psychedelics & Mental Health survey performed by Verywell Mind examines what Americans know and feel about psychedelics as mental health treatments.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Federal Court Ruling Favors Right To Perform Innovative Stem Cell Therapies

The ruling could have significant implications within America’s health care system.

Zenger

Dove, other Unilever dry shampoos recalled over cancer risk

Unilever Plc recalled popular brands of aerosol dry shampoo, including Dove, after discovering they were contaminated with a chemical called benzene that can cause cancer. The recall also covers brands such as Nexxus, Suave, Tresemmé and Tigi, which makes Rockaholic and Bed Head dry shampoos, according to a notice posted…

The Times of India

Sleep apnea device recall drags on, stoking anger from users

A massive recall of sleep apnea machines is expected to drag into next year

The Independent UK

Real-Life Cannabis Horror: Mother Charged With Murder After Her 4-Year-Old Dies From THC Edibles

Children falling ill from cannabis edibles is happening with more regularity as marijuana becomes mainstream as some adults are irresponsibly careless. And while, most of the time, kids end-up fully recovered, sometimes the things turn to real-life horror story.

Benzinga

Preparing for a world with Alzheimer's treatment

As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now treatments are on the horizon, the new race is to ready the health system.

360info

FDA recalls spicy noodles laced with toxic agent

The Food and Drug Administration (FDA) is recalling Mie Sedaap's Korean Spicy Chicken instant noodles due to reported contamination of the product caused by a pesticide.

Bangkok Post

What Do Biden's Cannabis Pardons Mean For Psychedelics? Can This Huge Cultural Shift In America Lead To Legalization?

This article by Partick McConnell was originally published on Microdose and appears here with permission.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Despite fears of another major interest rate hike by the Fed in response to the stubborn inflation data for September, stocks such as Microsoft (MSFT) and Biogen (BIIB) have shown remarkable stability. Hence, it may be the right time to invest in them for market-beating returns. Keep reading.

Tribune News Service

Weight loss gadgets: They provide data to help consumers achieve diet goals, but it still won’t be easy

I felt a special kind of awe, then panic, watching my glucose levels skyrocket for the first time after relishing a cold beer on a sweltering summer evening. It was a biological push notification from the fluid just beneath my skin that the carbohydrate-packed beverage was interfering with efforts to…

Reason

House Republicans Seek To Shield Kids From Talk About Gender, Sexual Orientation

Plus: Liz Truss resigns, declining internet freedom, new fentanyl seizure fuels Halloween candy panic, and more...

Benzinga

Apple Supplier Says Smartphone Market May Slump Into Next Year, Meta Loses Veteran Exec Behind Instagram and WhatsApp Acquisitions, Voyager Digital Seeks Creditors' Vote For Sale To FTX: Top Stories Thursday, Oct. 20

Bloomberg YouTube Named Google Play Executive As New Gaming Head

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

It's Long Past Time for the FDA To Approve Over-the-Counter Birth Control

Despite experts recommending that birth control be sold over the counter, the U.S. still treats the pill like it's 1960.

Axios

Preterm birth drug saga reflects broader issues with FDA process

Congress may still try to reform the FDA's accelerated approval process this year.

The Independent UK

US clears Novavax COVID booster dose

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

The Philadelphia Inquirer

FDA panel advises taking preterm birth drug off the market

An FDA advisory panel voted 14-1 on Wednesday to recommend that the agency withdraw its approval of the drug Makena, saying the treatment does not appear to reduce the risk of preterm birth.

Axios

FDA panel votes to remove early pregnancy drug from market

The Makena drug is the only one of its kind in the U.S.

The Independent UK

FDA panel backs removal of unproven pregnancy drug

A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn't work

Roll Call

FDA advisory committee votes to pull drug for premature births - Roll Call

The panel argued there was insufficient evidence to prove that the drug lowered the rate of premature birth.

1 … 174 175 176 177

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.